Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E Adjustments
Ratios

CASI Pharmaceuticals (CASI) Accumulated Depreciation & Amortization (2021 - 2024)

Historic Accumulated Depreciation & Amortization for Pharmaceuticals (CASI) over the last 4 years, with Q4 2024 value amounting to $1.3 million.

  • Pharmaceuticals' Accumulated Depreciation & Amortization fell 4800.0% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year decrease of 4800.0%. This contributed to the annual value of $1.3 million for FY2024, which is 4800.0% down from last year.
  • Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $1.3 million in Q4 2024, which was down 4800.0% from $2.5 million recorded in Q4 2023.
  • Over the past 5 years, Pharmaceuticals' Accumulated Depreciation & Amortization peaked at $2.5 million during Q4 2023, and registered a low of $500000.0 during Q4 2021.
  • Its 4-year average for Accumulated Depreciation & Amortization is $1.4 million, with a median of $1.2 million in 2022.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 14000.0% in 2022, then tumbled by 4800.0% in 2024.
  • Quarter analysis of 4 years shows Pharmaceuticals' Accumulated Depreciation & Amortization stood at $500000.0 in 2021, then surged by 140.0% to $1.2 million in 2022, then skyrocketed by 108.33% to $2.5 million in 2023, then tumbled by 48.0% to $1.3 million in 2024.
  • Its last three reported values are $1.3 million in Q4 2024, $2.5 million for Q4 2023, and $1.2 million during Q4 2022.